Balance Sheet
Liabilities and Shareholders Equity
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Long-Term Deferred Tax (2017 - 2024)

Aethlon Medical (AEMD) has disclosed Long-Term Deferred Tax for 5 consecutive years, with $33.3 million as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Long-Term Deferred Tax rose 10.78% year-over-year to $33.3 million, compared with a TTM value of $33.3 million through Mar 2024, up 10.78%, and an annual FY2024 reading of $33.3 million, up 10.78% over the prior year.
  • Long-Term Deferred Tax was $33.3 million for Q1 2024 at Aethlon Medical, up from $30.0 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $33.3 million in Q1 2024 and bottomed at $24.8 million in Q1 2021.
  • Average Long-Term Deferred Tax over 3 years is $29.3 million, with a median of $30.0 million recorded in 2023.
  • Peak annual rise in Long-Term Deferred Tax hit 10.78% in 2024, while the deepest fall reached 10.78% in 2024.
  • Year by year, Long-Term Deferred Tax stood at $24.8 million in 2021, then increased by 21.24% to $30.0 million in 2023, then grew by 10.78% to $33.3 million in 2024.
  • Business Quant data shows Long-Term Deferred Tax for AEMD at $33.3 million in Q1 2024, $30.0 million in Q1 2023, and $24.8 million in Q1 2021.